System Transmission

Top Signal

100#1 JOB

Activity

2179Ripe

+938 today

System

Livenow

Terminal Asset View

stockNASDAQ

CPRX

$23.23-0.68%

Catalyst Pharmaceuticals Inc

Ripening

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

53Ripening

Live Analysis Active

Company Mission

Catalyst Pharmaceuticals creates and markets prescription drugs for rare neurological conditions, like Lambert-Eaton myasthenic syndrome. Doctors prescribe these medicines to patients who need specialized treatment. The company makes money by selling these drugs to hospitals, pharmacies, and healthcare providers.

CPR

Industry Context

The biotech industry focuses on developing new medicines, especially for rare diseases where few treatments exist. Companies in this space can experience significant price moves when new drug data is released or regulatory decisions are made.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

74Matrix

Market Momentum

41.6— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

-0.68%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing CPRX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 12:09 PM UTC

As-of 03-15-2026 11:54 UTC

Develops and sells prescription drugs for rare neurological diseases, making money through sales to hospitals and specialty pharmacies.

Weekly price swings are getting smaller near recent levels, suggesting a potential breakout move is building.

Biotech sector volatility often creates opportunities, watch for a decisive move above or below the current tight range.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...